Global Hospital-Treated Gram-Negative Infections Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 124 pages | ID: GD8D40BD551EN
GlobalInfoResearch

Abstracts

Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of antimicrobials.

Scope of the Report:

The global Hospital-Treated Gram-Negative Infections market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital-Treated Gram-Negative Infections.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Hospital-Treated Gram-Negative Infections market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital-Treated Gram-Negative Infections market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Merck
• Pfizer
• AstraZeneca
• Abbott
• Lupin Pharmaceuticals
• Istituto lusofarmaco d’italia
• Adelco S.A
• Zhejiang yuntao biotechnology co., Ltd
• Alcon Laboratories

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Klebsiella
• Acinetobacter
• Coli
• cepacia
• Pseudomonas
• Serratia
• Enterobacter
• Others

Market Segment by Applications, can be divided into

• Hospital
• Lab

Contents

1 HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET OVERVIEW

1.1 Product Overview and Scope of Hospital-Treated Gram-Negative Infections
1.2 Classification of Hospital-Treated Gram-Negative Infections by Types
  1.2.1 Global Hospital-Treated Gram-Negative Infections Revenue Comparison by Types (2017-2023)
  1.2.2 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Types in 2017
  1.2.3 Klebsiella
  1.2.4 Acinetobacter
  1.2.5 Coli
  1.2.6 cepacia
  1.2.7 Pseudomonas
  1.2.8 Serratia
  1.2.9 Enterobacter
  1.2.10 Others
1.3 Global Hospital-Treated Gram-Negative Infections Market by Application
  1.3.1 Global Hospital-Treated Gram-Negative Infections Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital
  1.3.3 Lab
1.4 Global Hospital-Treated Gram-Negative Infections Market by Regions
  1.4.1 Global Hospital-Treated Gram-Negative Infections Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Hospital-Treated Gram-Negative Infections Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital-Treated Gram-Negative Infections Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital-Treated Gram-Negative Infections Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Hospital-Treated Gram-Negative Infections Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital-Treated Gram-Negative Infections Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital-Treated Gram-Negative Infections (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Business Overview
  2.1.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Merck Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
  2.2.1 Business Overview
  2.2.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Pfizer Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
  2.3.1 Business Overview
  2.3.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 AstraZeneca Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
  2.4.1 Business Overview
  2.4.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Abbott Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lupin Pharmaceuticals
  2.5.1 Business Overview
  2.5.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.6 Istituto lusofarmaco d’italia
  2.6.1 Business Overview
  2.6.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.7 Adelco S.A
  2.7.1 Business Overview
  2.7.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Adelco S.A Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.8 Zhejiang yuntao biotechnology co., Ltd
  2.8.1 Business Overview
  2.8.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
2.9 Alcon Laboratories
  2.9.1 Business Overview
  2.9.2 Hospital-Treated Gram-Negative Infections Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Alcon Laboratories Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET COMPETITION, BY PLAYERS

3.1 Global Hospital-Treated Gram-Negative Infections Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Hospital-Treated Gram-Negative Infections Players Market Share
  3.2.2 Top 10 Hospital-Treated Gram-Negative Infections Players Market Share
3.3 Market Competition Trend

4 GLOBAL HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET SIZE BY REGIONS

4.1 Global Hospital-Treated Gram-Negative Infections Revenue and Market Share by Regions
4.2 North America Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
4.5 South America Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS REVENUE BY COUNTRIES

5.1 North America Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
5.2 USA Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

6 EUROPE HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS REVENUE BY COUNTRIES

6.1 Europe Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
6.2 Germany Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
6.3 UK Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
6.4 France Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS REVENUE BY COUNTRIES

7.1 Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
7.2 China Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
7.5 India Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS REVENUE BY COUNTRIES

8.1 South America Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
8.2 Brazil Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS BY COUNTRIES

9.1 Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)

10 GLOBAL HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET SEGMENT BY TYPE

10.1 Global Hospital-Treated Gram-Negative Infections Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital-Treated Gram-Negative Infections Market Forecast by Type (2018-2023)
10.3 Klebsiella Revenue Growth Rate (2013-2023)
10.4 Acinetobacter Revenue Growth Rate (2013-2023)
10.5 Coli Revenue Growth Rate (2013-2023)
10.6 cepacia Revenue Growth Rate (2013-2023)
10.7 Pseudomonas Revenue Growth Rate (2013-2023)
10.8 Serratia Revenue Growth Rate (2013-2023)
10.9 Enterobacter Revenue Growth Rate (2013-2023)
10.10 Others Revenue Growth Rate (2013-2023)

11 GLOBAL HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET SEGMENT BY APPLICATION

11.1 Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Application (2013-2018)
11.2 Hospital-Treated Gram-Negative Infections Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Lab Revenue Growth (2013-2018)

12 GLOBAL HOSPITAL-TREATED GRAM-NEGATIVE INFECTIONS MARKET SIZE FORECAST (2018-2023)

12.1 Global Hospital-Treated Gram-Negative Infections Market Size Forecast (2018-2023)
12.2 Global Hospital-Treated Gram-Negative Infections Market Forecast by Regions (2018-2023)
12.3 North America Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
12.4 Europe Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
12.6 South America Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hospital-Treated Gram-Negative Infections Picture
Table Product Specifications of Hospital-Treated Gram-Negative Infections
Table Global Hospital-Treated Gram-Negative Infections and Revenue (Million USD) Market Split by Product Type
Figure Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Types in 2017
Figure Klebsiella Picture
Figure Acinetobacter Picture
Figure Coli Picture
Figure cepacia Picture
Figure Pseudomonas Picture
Figure Serratia Picture
Figure Enterobacter Picture
Figure Others Picture
Table Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Application (2013-2023)
Figure Hospital-Treated Gram-Negative Infections Revenue Market Share by Applications in 2017
Figure Hospital Picture
Figure Lab Picture
Table Global Market Hospital-Treated Gram-Negative Infections Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Hospital-Treated Gram-Negative Infections Type and Applications
Table Merck Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Hospital-Treated Gram-Negative Infections Type and Applications
Table Pfizer Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Hospital-Treated Gram-Negative Infections Type and Applications
Table AstraZeneca Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Hospital-Treated Gram-Negative Infections Type and Applications
Table Abbott Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Type and Applications
Table Lupin Pharmaceuticals Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Istituto lusofarmaco d’italia Basic Information, Manufacturing Base and Competitors
Table Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Type and Applications
Table Istituto lusofarmaco d’italia Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Adelco S.A Basic Information, Manufacturing Base and Competitors
Table Adelco S.A Hospital-Treated Gram-Negative Infections Type and Applications
Table Adelco S.A Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Zhejiang yuntao biotechnology co., Ltd Basic Information, Manufacturing Base and Competitors
Table Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Type and Applications
Table Zhejiang yuntao biotechnology co., Ltd Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Alcon Laboratories Basic Information, Manufacturing Base and Competitors
Table Alcon Laboratories Hospital-Treated Gram-Negative Infections Type and Applications
Table Alcon Laboratories Hospital-Treated Gram-Negative Infections Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Players (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue Share by Players (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Players in 2016
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Players in 2017
Figure Global Top 5 Players Hospital-Treated Gram-Negative Infections Revenue Market Share in 2017
Figure Global Top 10 Players Hospital-Treated Gram-Negative Infections Revenue Market Share in 2017
Figure Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Regions (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Regions (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Regions (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Market Share by Regions in 2017
Figure North America Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Europe Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure South America Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table North America Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
Table North America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure North America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure North America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries in 2017
Figure USA Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Canada Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Mexico Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table Europe Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure Europe Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries in 2017
Figure Germany Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure UK Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure France Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Russia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Italy Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries in 2017
Figure China Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Japan Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Korea Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure India Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table South America Hospital-Treated Gram-Negative Infections Revenue by Countries (2013-2018)
Table South America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure South America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure South America Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries in 2017
Figure Brazil Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Argentina Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Colombia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure UAE Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Egypt Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure Nigeria Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Figure South Africa Hospital-Treated Gram-Negative Infections Revenue and Growth Rate (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) by Type (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue Share by Type (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Type (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Type in 2017
Table Global Hospital-Treated Gram-Negative Infections Revenue Forecast by Type (2018-2023)
Figure Global Hospital-Treated Gram-Negative Infections Market Share Forecast by Type (2018-2023)
Figure Global Klebsiella Revenue Growth Rate (2013-2018)
Figure Global Acinetobacter Revenue Growth Rate (2013-2018)
Figure Global Coli Revenue Growth Rate (2013-2018)
Figure Global cepacia Revenue Growth Rate (2013-2018)
Figure Global Pseudomonas Revenue Growth Rate (2013-2018)
Figure Global Serratia Revenue Growth Rate (2013-2018)
Figure Global Enterobacter Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue by Application (2013-2018)
Table Global Hospital-Treated Gram-Negative Infections Revenue Share by Application (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Application (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Share by Application in 2017
Table Global Hospital-Treated Gram-Negative Infections Revenue Forecast by Application (2018-2023)
Figure Global Hospital-Treated Gram-Negative Infections Market Share Forecast by Application (2018-2023)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Lab Revenue Growth Rate (2013-2018)
Figure Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hospital-Treated Gram-Negative Infections Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hospital-Treated Gram-Negative Infections Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
Figure Europe Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
Figure South America Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hospital-Treated Gram-Negative Infections Revenue Market Forecast (2018-2023)